Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRUST-1: Remodulin in PAH
NCT00494533Phase 4Terminated
- Sponsor
- United Therapeutics Corporation
- Start
- Mar 2005
- Primary completion
- Oct 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of treprostinil in pulmonary arterial hypertension (PAH), sponsored by United Therapeutics Corporation. Started Mar 2005; status: terminated.
02
Drugs
treprostinil
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT00494533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00494533.